Steward Partners Investment Advisory, LLC Innate Pharma Sa Transaction History

Steward Partners Investment Advisory, LLC

  • $12.3 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$2.17 - $2.93 $651 - $879
-300 Reduced 60.0%
200 $0
Q3 2021

Nov 12, 2021
SELL
$3.04 - $8.1 $456 - $1,215
-150 Reduced 23.08%
500 $3,000
Q1 2021

May 14, 2021
SELL
$4.09 - $4.83 $1,840 - $2,173
-450 Reduced 40.91%
650 $2,000
Q4 2019

Jan 17, 2020
BUY
$5.66 - $6.55 $6,226 - $7,205
1,100 New
1,100 $7,000

Others Institutions Holding IPHA

# of Institutions
10
Shares Held
99.8K
Call Options Held
0
Put Options Held
0
View Full List

About Innate Pharma SA

IPHA Quotes by TradingView
  • Ticker IPHA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,893,000
  • Market Cap $165M
  • Description
  • Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...
More about IPHA
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email